|Articles|August 30, 2016

CMIC HOLDINGS Implements goBalto Activate

Japanese CRO CMIC HOLDINGS has chosen goBalto’s Activate solution to further its clinical study startup process throughout Asia.

Japanese CRO CMIC HOLDINGS has chosen goBalto’s Activate solution to further its clinical study startup process throughout Asia. The CRO looks for the solution to improve workflows of studies being conducted in Malaysia, Singapore, Taiwan, Philippines, Thailand, Japan and South Korea.
Read the full release here

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.